---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-095443"
form_type: "8-K"
ticker: "BTAI"
cik: "0001720893"
company_name: "BioXcel Therapeutics, Inc."
filed_at: "2021-07-23T23:59:59+00:00"
generated_at: "2026-06-30T02:59:49.045903+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BioXcel Therapeutics announces resignation of Chief Development Officer Reina Benabou effective July 30, 2021

## Summary
- Reina Benabou, M.D., Ph.D., Chief Development Officer, tendered resignation effective July 30, 2021.
- No successor or interim appointment announced in the filing.
- Benabou was a named executive officer in the company's April 2021 proxy statement.

## SEC filing metadata
- accession: 0001104659-21-095443
- form_type: 8-K
- ticker: BTAI
- cik: 0001720893
- company_name: BioXcel Therapeutics, Inc.
- filed_at: 2021-07-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/0001104659-21-095443-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/tm2122742d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-095443
- JSON: https://secwatch.observer/filing/0001104659-21-095443.json
- Plain text: https://secwatch.observer/filing/0001104659-21-095443.txt

## Key facts
- Executive change
  Reina Benabou resigned as Senior Vice President and Chief Development Officer at BioXcel Therapeutics, Inc..
  - Action: resigned
  - Role: Senior Vice President and Chief Development Officer
  source text: On July 19, 2021, Reina Benabou, M.D., Ph.D., Senior Vice President and Chief Development Officer of BioXcel Therapeutics, Inc. (the “Company”), and a named executive officer in the Company’s proxy statement filed April 27, 2021, tendered her resignation notice to the Company, effective July 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1720893/000110465921095443/0001104659-21-095443-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.